|
|
In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.
The FDA recognizes 118 routes of administration.
The first oncogene was discovered in 1970 and was termed SRC (pronounced "SARK").
More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.
Signs of depression include feeling sad most of the time for 2 weeks or longer; loss of interest in things normally enjoyed; lack of energy; sleep and appetite disturbances; weight changes; feelings of hopelessness, helplessness, or worthlessness; an inability to make decisions; and thoughts of death and suicide.